Akira Kanda Selected Research

Eosinophilia

2/2022	Pathogenic changes in group 2 innate lymphoid cells (ILC2s) in a steroid-insensitive asthma model of mice.
1/2017	IL-22/IL-22R1 signaling regulates the pathophysiology of chronic rhinosinusitis with nasal polyps via alteration of MUC1 expression.
10/2011	Allergic lung inflammation is mediated by soluble tumor necrosis factor (TNF) and attenuated by dominant-negative TNF biologics.
7/2010	Regulation of Th2 responses and allergic inflammation through bystander activation of CD8+ T lymphocytes in early life.
9/2009	Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akira Kanda Research Topics

Disease

19	Inflammation (Inflammations) 02/2022 - 06/2004
15	Asthma (Bronchial Asthma) 02/2022 - 04/2003
8	Rhinosinusitis 07/2021 - 10/2014
5	Eosinophilia 02/2022 - 09/2009
4	Nasal Polyps (Nasal Polyp) 01/2021 - 01/2017
3	Atopic Dermatitis (Atopic Eczema) 06/2014 - 04/2008
3	Pneumonia (Pneumonitis) 10/2011 - 04/2008
3	Respiratory Hypersensitivity 07/2010 - 04/2008
2	Infections 01/2021 - 12/2004
1	Airway Remodeling 02/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 09/2021
1	Wasting Syndrome (Wasting Disease) 09/2021
1	Seasonal Allergic Rhinitis (Hay Fever) 08/2021
1	Hearing Loss (Hearing Impairment) 01/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Nasal Obstruction 04/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2018
1	Paralysis (Palsy) 01/2017
1	Esophageal Neoplasms (Esophageal Cancer) 01/2017
1	Diphtheria 01/2015
1	Tetanus 01/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2015
1	Sinusitis 10/2014
1	Hyperplasia 10/2011
1	B-Cell Leukemia (Leukemia, B Cell) 11/2010
1	Lymphoma (Lymphomas) 11/2010
1	Lung Diseases (Lung Disease) 11/2010
1	Hypersensitivity (Allergy) 07/2010

Drug/Important Bio-Agent (IBA)

7	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2021 - 01/2017
6	AntigensIBA 02/2022 - 02/2008
5	CytokinesIBA 02/2022 - 09/2009
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2021 - 01/2015
3	OvalbuminIBA 02/2019 - 04/2008
3	Interleukin-5 (Interleukin 5)IBA 02/2019 - 09/2009
3	Immunoglobulin E (IgE)IBA 10/2011 - 04/2008
3	AllergensIBA 11/2010 - 02/2008
3	PPAR gammaIBA 11/2005 - 04/2003
2	SteroidsIBA 02/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 09/2021 - 11/2010
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2020 - 07/2010
2	VaccinesIBA 01/2015 - 05/2008
2	ChemokinesIBA 06/2014 - 07/2004
2	Immunoglobulin G (IgG)IBA 07/2010 - 04/2008
2	Prostaglandins DIBA 01/2007 - 01/2006
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2022
1	Monoclonal AntibodiesIBA 02/2022
1	entrectinibIBA 01/2022
1	Nonsense Codon (Nonsense Mutation)IBA 09/2021
1	RNA Precursors (Precursor, mRNA)IBA 09/2021
1	Antisense OligonucleotidesIBA 09/2021
1	DystrophinIBA 09/2021
1	Pharmaceutical PreparationsIBA 08/2021
1	Omalizumab (Xolair)FDA Link 07/2021
1	FibrinIBA 01/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	lenvatinibIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 04/2020
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2020
1	lysolecithin acylhydrolaseIBA 01/2019
1	Interleukin-22 (IL-22)IBA 01/2017
1	ExotoxinsIBA 01/2017
1	Formoterol Fumarate (Oxis)FDA Link 01/2017
1	Salmeterol Xinafoate (Serevent)FDA Link 01/2017
1	Serum AlbuminIBA 01/2017
1	Fluticasone (Cutivate)FDA LinkGeneric 01/2017
1	interleukin-22 receptor (IL-22R)IBA 01/2017
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2015
1	Diphtheria-Tetanus VaccineIBA 01/2015
1	AntibodiesIBA 01/2015
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2015
1	Amyloid (Amyloid Fibrils)IBA 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	ToxoidsIBA 01/2015
1	Amyloid beta-PeptidesIBA 01/2015
1	Protein Subunit VaccinesIBA 01/2015
1	Therapeutic UsesIBA 10/2014
1	Chemokine CX3CL1IBA 06/2014
1	Chemokine ReceptorsIBA 06/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2011
1	Methacholine Chloride (Methacholine)FDA Link 10/2011
1	Indicators and Reagents (Reagents)IBA 11/2010
1	Interleukin-10 (Interleukin 10)IBA 07/2010
1	Isoantigens (Alloantigen)IBA 07/2010
1	Interleukin-4 (Interleukin 4)IBA 07/2010
1	Interleukin-13IBA 07/2010
1	CollagenIBA 09/2009

Therapy/Procedure

4	Therapeutics 02/2022 - 10/2011
1	Intraperitoneal Injections 02/2019
1	Cholecystectomy 01/2019
1	Neck Dissection (Radical Neck Dissection) 10/2018
1	Metered Dose Inhalers (Metered Dose Inhaler) 01/2018
1	Dry Powder Inhalers 01/2017
1	Esophagectomy 01/2017
1	Nebulizers and Vaporizers (Inhaler) 10/2014
1	Aftercare (After-Treatment) 10/2014